A Randomised, Parallel-group, Double-blind, Placebo Controlled Study to Investigate the Efficacy and Safety of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Knee Replacement Surgery
Phase of Trial: Phase II
Latest Information Update: 10 Dec 2013
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 18 Dec 2007 Status changed from in progress to completed.
- 13 Nov 2007 Status changed from recruiting to in progress.
- 19 Nov 2005 New trial record.